Sarah Nexus statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.


Citations per year

Citations chart

Popular tool citations

chevron_left Chemical toxicity chevron_right
Popular tools chart

Tool usage distribution map

Tool usage distribution map

Associated diseases

Associated diseases

Sarah Nexus specifications


Unique identifier OMICS_18643
Name Sarah Nexus
Software type Framework/Library
Interface Graphical user interface
Restrictions to use License purchase required
Operating system Windows
Computer skills Medium
Version 2.0
Maintained Yes


Add your version


  • person_outline Georgia Clarke <>
  • person_outline Alex Cayley <>

Additional information

Access available upon request.

Publications for Sarah Nexus

Sarah Nexus in publication

PMCID: 4012781
PMID: 24808763
DOI: 10.1186/1480-9222-16-8

[…] such as the molecular weight or the number of benzene rings (molecular descriptors) using mathematical algorithms []. following are the some examples of commercial and publicly-available models:, •sarah nexus for prediction of the mutagenicity of chemicals []., •virtualtoxlab for prediction of the toxic potential (endocrine and metabolic disruption, some aspects of carcinogenicity […]

To access a full list of publications, you will need to upgrade to our premium service.

Sarah Nexus institution(s)
Lhasa Limited, Granary Wharf House, Leeds, UK; Janssen Research & Development, Spring House, PA, USA; Bayer Pharma AG, Investigational Toxicology, Muellerstr, Berlin, Germany; GlaxoSmithKline Pre-Clinical Development, Ware, UK; Novartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, Basel, Switzerland; Roche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland; Sanofi-Aventis Deutschland GmbH, R&D DSAR/Preclinical Safety FF, Industriepark Hoechst, Frankfurt, Germany; Vertex Pharmaceuticals, Discovery and Investigative Toxicology, Boston, MA, USA; Compound Safety Prediction, Pfizer Global Research & Development, Groton, CT, USA

Sarah Nexus reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review Sarah Nexus